Position in PGEN
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$114,000
+$36,600 QoQ
Shares Held
20,000
0.0% QoQ
Ownership
0.006%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#146
of 208 holders
Holding Since
Sep 2024
8 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in PGEN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026SMITH, MOORE & CO. holds $2,185,731 across 7 Biotechnology names. PGEN ranks #6 (5.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RVMD |
Revolution Medicines, Inc.
|
7,000 | $1,310,960 | |
| 2 | AXSM |
Axsome Therapeutics, Inc.
|
1,000 | $244,770 | |
| 3 | CORT |
Corcept Therapeutics Inc
|
2,440 | $212,158 | |
| 4 | GOSS |
Gossamer Bio, Inc.
|
900,000 | $148,500 | |
| 5 | AARD |
Aardvark Therapeutics, Inc.
|
20,000 | $115,200 | |
| 6 | PGEN |
Precigen, Inc.
This page
|
20,000 | $114,000 | |
| 7 | ALT |
Altimmune, Inc.
|
13,205 | $40,143 |
All Filings in PGEN
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $114,000 | 20,000 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $77,400 | 20,000 | Shares | Sole | 2026-05-05 | |
| 2025-12-31 | $83,600 | 20,000 | Shares | Sole | 2026-01-23 | |
| 2025-09-30 | $65,800 | 20,000 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $28,400 | 20,000 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $29,800 | 20,000 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $22,400 | 20,000 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $14,250 | 15,000 | Shares | Sole | 2024-11-12 | |
| No filing history on record for this holder in this stock. | ||||||